Home Drug Codes J Codes J9329 · TEVIMBRA
Updated July 1st, 2026

TEVIMBRA J Code: J9329

Injection, tislelizumab-jsgr, 1mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9329, effective October 1, 2026: $58.086 per HCPCS billing unit, down 0.1% from $58.169. From CMS's final file.

?
Medicare Payment Limit ?
$58.169
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$58.169
/ HCPCS billing unit · APC 0816
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, tislelizumab-jsgr, 1mg
HCPCS Added Date October 1, 2024
Manufacturer Beigene USA
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution, Concentrate

About TEVIMBRA

Tevimbra is a medication aligned to the HCPCS J Code: J9329 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Beigene USA.

According to CMS Drug Use Information: Depending on the brand, tislelizumab is used to treat certain types of cancer (esophageal, stomach, or throat). It works by changing the action of your own immune system, directing it to attack cancer cells. Tislelizumab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
72579-0121-01 Tevimbra BeOne Medicines USA, Inc. 100 100 MG / 10 ML
•••••-••••-•• Log in to view TEVIMBRA
Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

TEVIMBRA Pricing & Reimbursement

J9329 Private Payer Reimbursement
$60.24 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

TEVIMBRA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 22.03%
Avg. Days to File 7.8days
Avg. Days to Pay 22.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9329 claims analytics on FocalPoint →
OnPoint Oncology

TEVIMBRA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

TEVIMBRA Medically Unlikely Edits (MUE)

The most billing units of J9329 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
200 units / day
= 200 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

TEVIMBRA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Esophageal Squamous Cell Carcinoma Gastric or Gastroesophageal Junction Adenocarcinoma Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Tevimbra?
Billing and coding information for TEVIMBRA can be found through BEIGENE USA. Visit Here →
Are there any available patient assistance programs for Tevimbra?
TEVIMBRA patient assistance information can be found through BEIGENE USA. Visit Here →
Where can I find Tevimbra prescribing information?
Tevimbra prescribing information can be found at the link below. Visit Here →
Is there available side effect information for Tevimbra?
Side effect information for Tevimbra can be found through Medline Plus at the link below. Visit Here →
Does billing TEVIMBRA require JZ/JW wastage modifiers?
CMS does not include TEVIMBRA (J9329) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9329. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.